Table 12.
No. | Discovered Activity, (Pa) * | Reported Activity |
---|---|---|
129 | Atherosclerosis treatment (0.977) Antioxidant (0.963) Antihypercholesterolemic (0.956) Antiparkinsonian (0.955) Neurodegenerative diseases treatment (0.954) Alzheimer’s disease treatment (0.940) Antihyperlipoproteinemic (0.811) |
Activity not studied |
130 | Antihypercholesterolemic (0.958) Atherosclerosis treatment (0.890) Alzheimer’s disease treatment (0.838) Antioxidant (0.807) Neurodegenerative diseases treatment (0.801) |
Activity not studied |
131 | Antioxidant (0.922) Atherosclerosis treatment (0.908) Neurodegenerative diseases treatment (0.877) Antihypercholesterolemic (0.869) Alzheimer’s disease treatment (0.868) Antiparkinsonian (0.848) |
Activity not studied |
132 | Antihypercholesterolemic (0.909) Atherosclerosis treatment (0.876) Alzheimer’s disease treatment (0.828) Neurodegenerative diseases treatment (0.808) Biliary tract disorders treatment (0.807) |
Activity not studied |
* Only activities with Pa > 0.5 are shown.